"C44H60FN3O10"^^ . . . "Organic Chemical"^^ . "Pharmacologic Substance"^^ . "C2983992"^^ . "CanosimibePTNCI" . . "Canosimibe"^^ . "FDA"^^ . "Canosimibe"^^ . "2GG0K1I5CI"^^ . "768394-99-6"^^ . "C91027"^^ . "CANOSIMIBEPTFDA2GG0K1I5CI" . "A derivative of the cholesterol absorption inhibitor ezetimibe designed to be non-soluble and target the luminal surface of the GI tract. In Phase II trials canosimibe reduced LDL cholesterol levels, but it did not demonstrate the desired efficacy in a Phase III study, and was discontinued.NCI" .